[Federal Register Volume 75, Number 110 (Wednesday, June 9, 2010)]
[Notices]
[Page 32798]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-13821]
[[Page 32798]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
FDA-2010-N-0254
Preparation for International Cooperation on Cosmetic
Regulations; Public Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing a public
meeting entitled ``International Cooperation on Cosmetic Regulations
(ICCR)--Preparation for ICCR-4 Meetings in Toronto, Canada'' to provide
information and receive comments on the ICCR as well as the upcoming
meetings in Toronto, Canada. The topics to be discussed are the topics
for discussion at the forthcoming ICCR Steering Committee meeting. The
purpose of the meeting is to solicit public input prior to the next
Steering Committee and expert working group meetings in Toronto, Canada
the week of July 12, 2010.
Date and Time: The meeting will be held on Wednesday, July 7, 2010,
from 1:30 p.m. to 3:30 p.m.
Location: The meeting will be held in the Washington Theater at the
Hilton Washington DC/Rockville Hotel & Executive Meeting Center, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: All participants must register with Jennifer
Haggerty, Office of the Commissioner, Food and Drug Administration,
10903 New Hampshire Ave., Bldg. 31, rm. 3567, Silver Spring, MD 20903,
301-796-4600. Register by emailing: [email protected].
Registration and Requests for Oral Presentations: Send registration
information (including name, title, firm name, address, telephone, and
fax number), written material and requests to make oral presentation,
to the contact person by July 2, 2010.
If you need special accommodations due to a disability, please
contact Jennifer Haggerty (see Contact Person) at least 7 days in
advance.
Transcripts: Please be advised that as soon as a transcript is
available, it will be accessible at http://www.regulations.gov. It may
be viewed at the Division of Dockets Management (HFA-305), Food and
Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD. A
transcript will also be available in either hardcopy or on CD-ROM,
after submission of a Freedom of Information request. Written requests
are to be sent to Division of Freedom of Information (HFI-35), Office
of Management Programs, Food and Drug Administration, 5600 Fishers
Lane, rm. 6-30, Rockville, MD 20857.
SUPPLEMENTARY INFORMATION: The purpose of the multilateral framework on
the ICCR is to pave the way for the removal of regulatory obstacles to
international trade while maintaining global consumer protection.
ICCR is a voluntary international group of cosmetics regulatory
authorities from the United States, Japan, the European Union, and
Canada. These regulatory authority members will enter into constructive
dialogue with their relevant cosmetics' industry trade associations.
Currently, the ICCR members are Health Canada; the European Directorate
General for Enterprise and Industry; the Ministry of Health, Labor and
Welfare of Japan; and the U.S. Food and Drug Administration. All
decisions made by the consensus will be compatible with the laws,
policies, rules, regulations, and directives of the respective
administrations and governments. Members will implement and/or promote
actions or documents within their own jurisdictions and seek
convergence of regulatory policies and practices. Successful
implementation will require input from stakeholders.
Interested persons may present data, information, or views orally
or in writing, on issues pending at the public meeting. Time allotted
for oral presentations may be limited to 10 minutes. Those desiring to
make oral presentations should notify the contact person by July 2,
2010, and submit a brief statement of the general nature of the
evidence or arguments they wish to present, the names and addresses,
telephone number, fax, and e-mail of proposed participants, and an
indication of the approximate time requested to make their
presentation.
The agenda for the public meeting will be made available on the
Internet at: http://www.fda.gov/Cosmetics/InternationalActivities/ConferencesMeetingsWorkshops.
Dated: June 4, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-13821 Filed 6-8-10; 8:45 am]
BILLING CODE 4160-01-S